Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVITIUM PHARMA

  • FDA Approval
  • March 08, 2023, 12:39 UTC
  • 31
  • 0 comments

FDA approve TADALAFIL

Comment Full text

INVENTIA

  • FDA Approval
  • March 08, 2023, 12:39 UTC
  • 33
  • 0 comments

FDA approve TELMISARTAN

Comment Full text

AIZANT

  • FDA Approval
  • March 08, 2023, 12:39 UTC
  • 32
  • 0 comments

FDA approve DAPAGLIFLOZIN

Comment Full text

SHORLA

  • FDA Approval
  • March 08, 2023, 12:39 UTC
  • 35
  • 0 comments

FDA approve NELARABINE

Comment Full text

SCIEGEN PHARMS INC

  • FDA Approval
  • March 08, 2023, 12:39 UTC
  • 33
  • 0 comments

FDA approve NAPROXEN

Comment Full text

LUPIN

  • FDA Approval
  • March 08, 2023, 12:39 UTC
  • 35
  • 0 comments

FDA approve SERTRALINE HYDROCHLORIDE

Comment Full text

ALEMBIC

  • FDA Approval
  • March 08, 2023, 12:39 UTC
  • 34
  • 0 comments

FDA approve ADAPALENE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • March 07, 2023, 18:24 UTC
  • 33
  • 0 comments

FDA approve USTEKINUMAB

Comment Full text

CENTOCOR ORTHO BIOTECH INC

  • FDA Approval
  • March 07, 2023, 18:21 UTC
  • 32
  • 0 comments

FDA approve USTEKINUMAB

Comment Full text

DARE

  • FDA Approval
  • March 07, 2023, 18:18 UTC
  • 33
  • 0 comments

FDA approve CLINDAMYCIN PHOSPHATE

Comment Full text
  • Previous
  • 868
  • 869
  • 870
  • 871
  • 872
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243092)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin